Los Angeles Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1K Hold
690
– – ﹤0.01% 1962
2026
Q1
$5.12K Hold
690
– – ﹤0.01% 2123
2025
Q4
$6.69K Buy
+690
New +$7.44K ﹤0.01% 2217
2025
Q1
– Sell
-70,331
Closed -$1.16M – 1166
2024
Q4
$1.16M Sell
70,331
-4,302
-6% -$66.8K ﹤0.01% 575
2024
Q3
$1.1M Buy
+74,633
New +$1.17M ﹤0.01% 623
2024
Q2
– Sell
-20,925
Closed -$329K – 1252
2024
Q1
$329K Hold
20,925
– – ﹤0.01% 977
2023
Q4
$339K Sell
20,925
-470
-2% -$7.69K ﹤0.01% 979
2023
Q3
$263K Sell
21,395
-2,806
-12% -$41.7K ﹤0.01% 999
2023
Q2
$389K Buy
+24,201
New +$399K ﹤0.01% 932
2021
Q4
– Sell
-6,998
Closed -$338K – 1450
2021
Q3
$338K Hold
6,998
– – ﹤0.01% 1250
2021
Q2
$316K Sell
6,998
-10,330
-60% -$458K ﹤0.01% 1367
2021
Q1
$836K Sell
17,328
-48,571
-74% -$2.53M ﹤0.01% 978
2020
Q4
$3.55M Sell
65,899
-8,540
-11% -$386K 0.02% 481
2020
Q3
$2.75M Sell
74,439
-3,960
-5% -$147K 0.01% 492
2020
Q2
$2.43M Sell
78,399
-3,075
-4% -$85.2K 0.01% 562
2020
Q1
$2.25M Sell
81,474
-7,255
-8% -$217K 0.01% 506
2019
Q4
$2.6M Sell
88,729
-42,942
-33% -$1.02M 0.01% 570
2019
Q3
$2.52M Sell
131,671
-1,275
-1% -$29.9K 0.01% 566
2019
Q2
$2.92M Buy
132,946
+99,927
+303% +$2.19M 0.02% 560
2019
Q1
$676K Sell
33,019
-31,115
-49% -$541K ﹤0.01% 994
2018
Q4
$809K Buy
64,134
+14,405
+29% +$215K 0.01% 811
2018
Q3
$763K Buy
+49,729
New +$687K ﹤0.01% 971

Other funds holding NEO

Los Angeles Capital Management's NEO Position: Q2 2026 in Review

Los Angeles Capital Management held its NeoGenomics (NEO) position steady in Q2 2026 at 690 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Los Angeles Capital Management first reported a position in NEO in Q3 2018 and has held it in 22 quarters since. The position peaked at $3.55M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Los Angeles Capital Management held 690 shares of NeoGenomics worth $10.1K as of Q2 2026.
  • Los Angeles Capital Management left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1962 holding.
  • Los Angeles Capital Management first reported a position in NeoGenomics in Q3 2018 and has held it in 22 quarters since.
  • Los Angeles Capital Management's NeoGenomics position peaked at $3.55M in Q4 2020.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.